Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Eur Respir J ; 46(6): 1636-44, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26381519

ABSTRACT

Asthma patients show evidence of a procoagulant state in their airways, accompanied by an impaired function of the anticoagulant protein C system. We aimed to study the effect of recombinant human activated protein C (rhAPC) in allergic asthma patients.We conducted a randomised, double-blind, placebo-controlled, proof-of-concept study in house dust mite (HDM) allergic asthma patients. Patients were randomised to receive intravenous rhAPC (24 µg·kg(-1)·h(-1); n=12) or placebo (n=12) for 11 h. 4 h after the start of infusion, a first bronchoscopy was performed to challenge one lung segment with saline (control) and a contralateral segment with a combination of HDM extract and lipopolysaccharide (HDM+LPS), thereby mimicking environmental house dust exposure. A second bronchoscopy was conducted 8 h after intrabronchial challenge to obtain bronchoalveolar lavage fluid (BALF).rhAPC did not influence HDM+LPS induced procoagulant changes in the lung. In contrast, rhAPC reduced BALF leukocyte counts by 43% relative to placebo, caused by an inhibitory effect on neutrophil influx (64% reduction), while leaving eosinophil influx unaltered. rhAPC also reduced neutrophil degranulation products in the airways.Intravenous rhAPC attenuates HDM+LPS-induced neutrophil migration and protein release in allergic asthma patients by an effect that does not rely on coagulation inhibition.


Subject(s)
Asthma/drug therapy , Cell Movement/drug effects , Dermatophagoides pteronyssinus/immunology , Neutrophils/drug effects , Protein C/pharmacology , Respiratory Hypersensitivity/drug therapy , Tissue Extracts/pharmacology , Administration, Intravenous , Adult , Allergens/pharmacology , Animals , Anticoagulants/pharmacology , Asthma/immunology , Bronchoalveolar Lavage Fluid/cytology , Bronchoscopy , Cell Movement/immunology , Double-Blind Method , Female , Humans , Lipopolysaccharides/pharmacology , Male , Neutrophils/immunology , Recombinant Proteins/pharmacology , Respiratory Hypersensitivity/immunology , Tissue Extracts/immunology , Young Adult
2.
Tuberculosis (Edinb) ; 95(5): 575-80, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26156785

ABSTRACT

Tuberculosis (TB) is an important cause of morbidity and mortality worldwide. Granzymes (gzms) are proteases mainly found in cytotoxic lymphocytes, but also extracellularly. While the role of gzms in target cell death has been widely characterized, considerable evidence points towards broader roles related to infectious and inflammatory responses. To investigate the expression of the gzms in TB, intracellular gzms A, B and K were measured by flow cytometry in lymphocyte populations from peripheral blood mononuclear cells from 18 TB patients and 12 healthy donors from Bangladesh, and extracellular levels of gzmA and B were measured in serum from 58 TB patients and 31 healthy controls. TB patients showed increased expression of gzmA in CD8(+) T, CD4(+) T and CD56(+) T, but not NK, cells, and of gzmB in CD8(+) T cells, when compared to controls. GzmK expression was not altered in TB patients in any lymphocyte subset. The extracellular levels of gzmA and, to a lesser extent, of gzmB, were increased in TB patients, but did not correlate with intracellular gzm expression in lymphocyte subsets. Our results reveal enhanced intra- and extracellular expression of gzmA and B in patients with pulmonary TB, suggesting that gzms are part of the host response to tuberculosis.


Subject(s)
Granzymes/blood , T-Lymphocytes/enzymology , Tuberculosis/blood , Tuberculosis/enzymology , Adult , Bangladesh , Biomarkers/blood , Case-Control Studies , Female , Flow Cytometry , Host-Pathogen Interactions , Humans , Male , Mycobacterium tuberculosis/immunology , Mycobacterium tuberculosis/pathogenicity , T-Lymphocytes/immunology , T-Lymphocytes/microbiology , Tuberculosis/diagnosis , Tuberculosis/immunology , Tuberculosis/microbiology , Up-Regulation , Young Adult
3.
Haematologica ; 98(11): 1797-803, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23911704

ABSTRACT

Activated polymorphonuclear neutrophils play an important role in the pathogenesis of vaso-occlusive painful sickle cell crisis. Upon activation, polymorphonuclear neutrophils can form neutrophil extracellular traps. Neutrophil extracellular traps consist of a meshwork of extracellular DNA, nucleosomes, histones and neutrophil proteases. Neutrophil extracellular traps have been demonstrated to be toxic to endothelial and parenchymal cells. This prospective cohort study was conducted to determine neutrophil extracellular trap formation in sickle cell patients during steady state and painful crisis. As a measure of neutrophil extracellular traps, plasma nucleosomes levels were determined and polymorphonuclear neutrophil activation was assessed measuring plasma levels of elastase-α1-antitrypsin complexes in 74 patients in steady state, 70 patients during painful crisis, and 24 race-matched controls using Enzyme Linked Immunosorbent Assay. Nucleosome levels in steady state sickle cell patients were significantly higher than levels in controls. During painful crisis levels of both nucleosomes and elastase-α1-antitrypsin complexes increased significantly. Levels of nucleosomes correlated significantly to elastase-α1-antitrypsin complex levels during painful crisis, (Sr = 0.654, P<0.001). This was seen in both HbSS/HbSß(0)-thalassemia (Sr=0.55, P<0.001) and HbSC/HbSß(+-)thalassemia patients (Sr=0.90, P<0.001) during painful crisis. Levels of nucleosomes showed a correlation with length of hospital stay and were highest in patients with acute chest syndrome. These data support the concept that neutrophil extracellular trap formation and neutrophil activation may play a role in the pathogenesis of painful sickle cell crisis and acute chest syndrome.


Subject(s)
Anemia, Sickle Cell/blood , Anemia, Sickle Cell/epidemiology , Neutrophil Activation/physiology , Nucleosomes/metabolism , Pain/blood , Pain/epidemiology , Adult , Anemia, Sickle Cell/diagnosis , Female , Humans , Male , Middle Aged , Pain/diagnosis , Prospective Studies , Young Adult
4.
Arterioscler Thromb Vasc Biol ; 33(1): 147-51, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23104849

ABSTRACT

OBJECTIVE: The formation of neutrophil extracellular traps and the exposure of nucleosomes on these neutrophil extracellular traps contribute to coagulation activation and the propagation of deep vein thrombosis (DVT) in animal models. However, no data are available on the role of neutrophil extracellular traps or nucleosomes in patients with thrombosis. METHODS AND RESULTS: We conducted a case-control study, in which levels of circulating nucleosomes and neutrophil elastase-α1-antitrypsin complexes were assessed in plasma from 150 patients with objectified symptomatic DVT (cases) and compared with 195 patients with a clinical suspicion of DVT but in whom DVT was excluded (controls). We explored the association between both nucleosomes and elastase-α1-antitrypsin complexes, and the presence of DVT by calculating the odds ratio with corresponding 95% CIs. Elevated levels of both circulating nucleosomes and elastase-α1-antitrypsin complexes were associated with a 3-fold risk of DVT, and the associations remained similar after adjustment for potential confounders (malignancy, smoking, recent immobilization, recent hospitalization). The risk increased with higher nucleosome and elastase-α1-antitrypsin complex levels, suggesting a dose-dependent relationship among circulating nucleosomes, activated neutrophils, and DVT. CONCLUSIONS: Our study suggests an association among circulating nucleosomes, activated neutrophils, and presence of DVT in humans, which might have implications for treatment and prevention.


Subject(s)
Neutrophil Activation , Neutrophils/immunology , Nucleosomes/metabolism , Venous Thrombosis/etiology , Adult , Biomarkers/blood , Case-Control Studies , Female , Humans , Leukocyte Elastase/blood , Logistic Models , Male , Middle Aged , Multivariate Analysis , Neutrophils/enzymology , Odds Ratio , Risk Assessment , Risk Factors , Up-Regulation , Venous Thrombosis/blood , Venous Thrombosis/diagnosis , Venous Thrombosis/immunology , alpha 1-Antitrypsin/blood
5.
Crit Care Med ; 31(7): 1947-51, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12847387

ABSTRACT

OBJECTIVE: Multiple organ dysfunction syndrome is a frequent complication of severe sepsis and septic shock and has a high mortality. We hypothesized that extensive apoptosis of cells might constitute the cellular basis for this complication. DESIGN: Retrospective study. SETTING: Medical and surgical wards or intensive care units of two university hospitals. PATIENTS: Fourteen patients with fever, 15 with systemic inflammatory response syndrome, 32 with severe sepsis, and eight with septic shock. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We assessed circulating levels of nucleosomes, specific markers released by cells during the later stages of apoptosis, with a previously described enzyme-linked immunosorbent assay in these 69 patients with fever, systemic inflammatory response syndrome, severe sepsis, or septic shock. Severity of multiple organ dysfunction syndrome was assessed with sepsis scores, and clinical and laboratory variables. Elevated nucleosome levels were found in 64%, 60%, 94%, and 100% of patients with fever, systemic inflammatory response syndrome, severe sepsis, or septic shock, respectively. These levels were significantly higher in patients with septic shock as compared with patients with severe sepsis, systemic inflammatory response syndrome, or fever, and in nonsurvivors as compared with survivors. In patients with advanced multiple organ dysfunction syndrome, nucleosome levels correlated with cytokine plasma levels as well as with variables predictive for outcome. CONCLUSIONS: Patients with severe sepsis and septic shock have elevated plasma levels of nucleosomes. We suggest that apoptosis, probably resulting from exposure of cells to excessive amounts of inflammatory mediators, might by involved in the pathogenesis of multiple organ dysfunction syndrome.


Subject(s)
Multiple Organ Failure/diagnosis , Nucleosomes/metabolism , Shock, Septic/diagnosis , Systemic Inflammatory Response Syndrome/diagnosis , Adult , Aged , Aged, 80 and over , Apoptosis/physiology , Biomarkers/blood , Enzyme-Linked Immunosorbent Assay , Female , Hospital Mortality , Humans , Intensive Care Units , Male , Middle Aged , Multiple Organ Failure/blood , Multiple Organ Failure/mortality , Predictive Value of Tests , Prognosis , Shock, Septic/blood , Shock, Septic/mortality , Survival Rate , Systemic Inflammatory Response Syndrome/blood , Systemic Inflammatory Response Syndrome/mortality
6.
Immunology ; 109(4): 564-71, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12871224

ABSTRACT

Activation of complement is a biological function of human C-reactive protein (hCRP), whereas rat CRP (rCRP) has been claimed to be unable to activate complement. As important biological functions of proteins are probably conserved among species, we re-evaluated, using various ligands, the capability of rCRP to activate complement. The activation of complement by hCRP and rCRP was investigated in solid- and fluid-phase systems. In the solid-phase system, purified CRP was fixed to enzyme-linked immunosorbent assay (ELISA) plates and incubated with human or rat recalcified plasma. Dose-dependent binding of human and rat C3 and C4 was observed to human and rat CRP, respectively. In the fluid-phase system, recalcified rat plasma, which contains about 500 mg/l of CRP, or human plasma supplemented with hCRP, were incubated with lyso-phosphatidylcholine. A dose-dependent activation of complement was observed upon incubation with this ligand, as reflected by the generation of activated C4 as well as of CRP-complement complexes. This activation was, in both cases, inhibited by preincubation of plasma with p-aminophosphorylcholine, a specific inhibitor of the interaction of CRP with its ligands, or by chelation of calcium ions. We conclude that rat CRP, similarly to human CRP, can activate autologous complement. These results support the notion that opsonization of ligands with complement is an important biological function of CRP.


Subject(s)
C-Reactive Protein/immunology , Complement Activation/immunology , Animals , Antibody Specificity/immunology , Complement C3/immunology , Complement C4/immunology , Dose-Response Relationship, Immunologic , Enzyme-Linked Immunosorbent Assay/methods , Humans , Ligands , Lysophosphatidylcholines/immunology , Polysaccharides, Bacterial/immunology , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...